velsecorat: Clinical Trials

5 completed. 4 Phase 1, 1 Phase 2.

By phase and status

Phase	Trials	Status
Phase 1	4	Completed 4
Phase 2	1	Completed 1

Follow velsecorat: new trials by email Literature Review of velsecorat trials Research Report on velsecorat

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects. AZD7594 - Asthma	Phase 1	Completed	AstraZeneca	24	2019-09-19	2019-12-16
A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma AZD7594 - Asthma	Phase 1	Completed	AstraZeneca	36	2019-07-24	2021-01-29
A Study to Evaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male Participants Abediterol, AZD7594, AZD7594/abediterol - Chronic Obstructive Pulmonary Disease (COPD), Asthma	Phase 1	Completed	AstraZeneca	14	2016-11-24	2018-02-13
A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma 800 μg AZD7594 once daily, 250 µg AZD7594 once daily, 58 µg AZD7594 once daily - Asthma, Efficacy	Phase 2	Completed	AstraZeneca	54	2015-06-25	2018-02-15
To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD7594 AZD7594, Placebo to match - Safety, Pharmacokinetics	Phase 1	Completed	AstraZeneca	73	2012-09-01	2013-06-20

Conditions studied

Asthma (4)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

AstraZeneca (5)

Countries

Germany (3)  ·  Bulgaria (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Andrea Ludwig-Sengpiel, Dr. (1)  ·  Anne-Marie Kirsten, Dr. (1)  ·  Anneliese Linnhoff, Dr. med. (1)  ·  Carin Jorup, MD (1)  ·  Christine Grigat, Dr. (1)  ·  Dirk Skowasch, Prof. (1)  ·  Jutta Beier, Dr. med. (1)  ·  Margret Jandl, Dr. (1)  ·  Oliver Kornmann, Dr. (1)  ·  Rainard Fuhr (1)  ·  Rainard Fuhr, Dr. med. (1)  ·  Tanya Kralimarkova, Dr. (1)  ·  Ulrike Westerhausen, Dr. (1)

Results publications

PMID 30777086

NIH funding

2014 (1)